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ABSTRACT The amino acid compositions of the radioac-
tive peptides obtained from trypsin digestion of ['4C]benzyl-
penicillin-labeled penicillin-binding proteins (PBPs) 1A, 1B,
and 3 of Escherichia coli have been obtained. Complete diges-
tion of these peptides with a combination of aminopeptidase M
and carboxypeptidase Y showed that benzylpenicillin was
bound to a serine residue in each of these proteins. Compari-
son of the compositions of the penicillin-labeled peptides with
the complete amino acid sequences of PBPs 1A, 1B, and 3
showed that the acylated serine occurs near the middle of each
of the proteins, within the conserved sequence Gly-Ser-Xaa-
Xaa-Lys-Pro. The sequence around the acylated serine of these
high Mr PBPs shows little similarity to that around the acylat-
ed serine of the low-Mr PBPs (D-alanine carboxypeptidases) or
of the class A or class C 3-lactamases, except that in all of
these enzymes which interact with penicillin the acylated ser-
ine residue occurs within the sequence Ser-Xaa-Xaa-Lys.
f3Lactam antibiotics interact with three classes of enzymes.
The ,B-lactamases hydrolyze penicillin and protect bacteria
against the lethal effects of the antibiotic (1). The high-Mr
penicillin-binding proteins (PBPs) are bifunctional enzymes
that catalyze both a penicillin-insensitive peptidoglycan
transglycosylase reaction and a penicillin-sensitive peptido-
glycan transpeptidase reaction (2-4). These enzymes are re-
quired for the synthesis and incorporation of peptidoglycan
precursors into the cell wall and are essential for the growth
and morphogenesis of the bacterial cell (4, 5). The lethal ef-
fects of penicillin are due to the inactivation of the high-Mr
PBPs (6). The low-Mr PBPs are D-alanine carboxypeptidases
that catalyze the removal of the terminal D-alanine residue
from the pentapeptide side chains of peptidoglycan precur-
sors (4, 5). Inhibition of these enzymes is not lethal and their
precise role in bacterial growth is unknown (4, 5).
Penicillin has been proposed to be an analog of the termi-
nal acyl-D-alanyl-D-alanine moiety of the pentapeptide side-
chain of the precursor in peptidoglycan synthesis (7). It has
been suggested that the antibiotic acylates an active-site resi-
due of penicillin-sensitive enzymes to form a stable, inac-
tive, "penicilloyl-enzyme" that is analogous to the transient
acyl-enzyme formed with the cell wall peptide substrate dur-
ing catalysis. In the D-alanine carboxypeptidase reaction,
the acyl-enzyme is formed with the release of the terminal D-
alanine residue of the substrate, and the acyl moiety is then
transferred to H20 to regenerate the active enzyme (5, 8).
For all D-alanine carboxypeptidases so far examined [with
the exception of a mechanistically distinct zinc enzyme (9)]
penicillin acylates a serine residue (10) that is located close
to the NH2 terminus (11-13). Evidence in support of the sub-
strate-analog hypothesis for the mechanism of action of f-
lactam antibiotics has been obtained by the demonstration
that penicillin and a synthetic substrate (diacetyl-L-lysyl-D-
alanyl-D-lactate) acylate the same serine residue of the D-
alanine carboxypeptidases of Bacillus subtilis and Bacillus
stearothermophilus (11, 12).
The class A &3lactamases (typified by strain TEM (3lac-
tamase) and the class C 3-lactamases (typified by the chro-
mosomal ,3lactamase of Escherichia colt) have also been
shown to utilize an acyl-enzyme mechanism (14, 15) involv-
ing acylation of a serine residue close to the NH2 terminus of
these proteins (16, 17), and the f3-lactamases and D-alanine
carboxypeptidases appear to be mechanistically similar.
The transpeptidase reaction catalyzed by the essential
high Mr PBPs has been proposed to be similar to that of the
D-alanine carboxypeptidases, except that the acyl moiety is
transferred from the acyl-enzyme to an amino group of a
neighboring peptide side chain to achieve crosslinking of the
peptidoglycan (5, 8). However, information about the inter-
action of penicillin with these physiologically important
PBPs is still lacking.
In E. coli the high Mr PBPs 1A, 1B, 2, and 3 have been
identified as the essential PBPs that are the targets of the
killing action of (-lactam antibiotics (4, 6). We show here
that penicillin binds to a serine residue in PBPs 1A, 1B, and 3
of E. coli and that the acylated serine residue is located close
to the middle of these proteins, within the conserved se-
quence Gly-Ser-Xaa-Xaa-Lys-Pro.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. PBP 1A was purified from
E. coli KN126 trp tyr ilv sup-126 carrying the runaway-repli-
cation plasmid pWK12-4, a derivative of pOU71 (18) con-
taining the ponA gene (unpublished data). PBP 1B was puri-
fied from E. coli JE5615 ponA(ts) ponB dap lys metB proA
carrying the runaway-replication plasmid pHK231, a deriva-
tive of pBEU17 (19) containing the ponB gene (kindly pro-
vided by H. Kraut and Y. Hirota). PBP 3 was purified from
E. coli JE7627 ponB dacB dap lys metB proA ilvH leuA car-
rying pWK7, a derivative of pBEU17 containing the pbpB
gene (unpublished data).
Purification of PBPs 1A, 1B, and 3. E. coli KN126(pWK12-
4) was grown at 30°C to mid-logarithmic phase and then
transferred to 42°C for 3 hr to allow runaway replication of
the plasmid encoding PBP 1A. Approximately 50-fold over-
production of PBP 1A was obtained under these conditions;
the protein was purified by chromatography on heparin-
Sepharose CL-6B followed by 6-aminopenicillanic acid-sub-
stituted CH-Sepharose 4B. E. coli JE5615(pHK231) was
grown at 30°C and was shifted to 42°C (as above) to achieve
150-fold overproduction ofPBP 1B. The protein was purified
by affinity chromatography on ampicillin-substituted CH-
Sepharose 4B as described (20). E. coli JE7627(pWK7) was
Abbreviation: PBP, penicillin-binding protein.
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grown as above to achieve 150-fold overproduction of
PBP 3. The protein was purified by affinity chromatography
on cephalexin-substituted CH-Sepharose 4B as described
(20).
Isolation and Analysis of ['4C]Benzylpenicillin-Labeled
Tryptic Peptides. Purified PBPs (17-99 nmol) were labeled
with a 3- to 6-fold molar excess of [14C]benzylpenicillin (54
Ci/mol, Amersham International; 1 Ci = 37 GBq) for 15 min
at 37°C. Under these conditions, PBPs 1A, 1B, and 3 were
32%, 25%, and 2% saturated with penicillin, respectively.
The cause of the low level of binding to purified PBP 3 is
unclear, but such binding was obtained in several indepen-
dent experiments. The penicilloylated PBPs were denatured
and digested with trypsin as described (13). The tryptic di-
gests were dissolved in 200 ,u1 of H20, and 180-190 IL1 was
used for HPLC fractionation on a Hypersil ODS column (250
x 4.6 mm; 3-,pm particles, Bischoff, F.R.G.) as described
(13). The column was eluted with a linear 0-100% gradient of
buffer B in buffer A over 3 hr at a column temperature of
30°C and a flow rate of 0.7 ml/min. [Buffer A was 50 mM
phosphate buffer, pH 4.0, containing 0.17 mM sodium azide;
buffer B was 70% (vol/vol) methanol in 50 mM phosphate
buffer, pH 4.0.] Fractions (210 p.1) were collected at 18-sec
intervals and the radioactivity of 2-,ul aliquots was mea-
sured. The radioactive fractions were pooled and lyophi-
lized. The radiolabeled fragments for PBP 1A and PBP 1B
were further purified by HPLC with a linear 30-100% gradi-
A 2000-
T 1500-
41000
500-
0
40-
30-
¶20-
10
ent of buffer D in buffer C over 70 min. [Buffer C was 50 mM
phosphate buffer, pH 5.5, containing 0.06 mM sodium azide;
buffer D was 70% (vol/vol) methanol in 50 mM phosphate
buffer, pH 5.5.] The radiolabeled fragments of PBP 3 were
analyzed without further purification. The purified [14C]ben-
zylpenicillin-labeled tryptic peptides were hydrolyzed in 4 M
HCl for 14 hr at 104'C under nitrogen. The hydrolysates
were dansylated essentially as described (21) and analyzed
by HPLC, using a linear 35-80% gradient of methanol in 35
mM phosphate buffer, pH 6.5, with a column temperature of
40'C and a flow rate of 0.8 ml/min. Fluorescence was moni-
tored with a Perkin-Elmer 3000 micro flow cell (excitation at
330 nm, emission at 545 nm). For calibration, standards with
50 pmol of each amino acid and of acid-hydrolyzed benzyl-
penicillin were run; the detection limit was 1 pmol for a pure
standard. Blank values were used for background correc-
tion.
Proteolytic Digestion of Purified Tryptic Peptides. Partial
aminopeptidase M digestion of the [14C]benzylpenicillin-
labeled tryptic peptide II of PBP 1B was carried out for 90
min at 25°C in 40 mM Tris Cl buffer, pH 6.7/8 mM MgSO4
with 0.2 unit of enzyme (4 units/mg; Boehringer Mannheim)
and 450 pmol of peptide in a total volume of 250 ,ul. The
reaction was terminated by the addition of ice-cold glacial
acetic acid to a final concentration of 10%, and the sample
was lyophilized and then dissolved in 200 ,ul of water. The
sample (190 ,ul) was fractionated by HPLC; elution was with
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FIG. 1. Purification of [14C]benzylpenicillin-labeled tryptic peptides of PBPs 1A, 1B, and 3. Purified PBPs 1A, 1B, and 3 (17, 33, and 99
nmol, respectively) were labeled with [14C]benzylpenicillin, digested with trypsin, and the peptides were fractionated by HPLC. The radiola-
beled peptides obtained from PBP 1A (A) and PBP 1B (B) were purified further by HPLC, and the relevant parts of the elution profiles of the
peptides from the latter column are shown. The radiolabeled peptides from PBP 3 were not purified further, and the relevant part of the elution
profile from the initial HPLC column is shown (C).
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Table 1. Amino acid analysis of ['4C]benzylpenicillin-labeled peptides
Amount
analyzed, Molar ratios of components of the peptides
Fragment pmol Asx Pen* Glx Ser Gly Thr Ala Pro Val Ile Leu Phe Lys
PBP 1A fragment II 71 1.1 0.8 1.0 0.9 0.9 0 0 1.3 1.2 0.9 0 1.1 0.8
PBP 1A fragment II after
aminopeptidase and
carboxypeptidase digestion 62 0 1.2 0.1 1.0 0.1 0 0 0.2 0 0 0 0 0
PBP 1B fragment II 131 0 0.7 0 2.0 1.0 0 1.2 0 0 0.9 1.0 0 1.0
PBP 1B fragment II after partial
aminopeptidase digestion 100 0 l.t 1.0 0 0 1.2 0 0 0 1.1 0 0.9
PBP 1B fragment II after
aminopeptidase and
carboxypeptidase digestion 35 0 1.1 0 1.0 0 0 0 0 0 0 0 0 0
PBP 3 fragment I 24 0.9 2.Ot 0.8 1.0 3.2 -0.1 2.2 2.1 1.1 0 0.8 1.1
PBP 3 fragment I after
aminopeptidase and
carboxypeptidase digestion 14 0 1.3 0 1.0 0.1 0.1 0 -0.1 0 0 0 0 0
The purified ['4C]benzylpenicillin-labeled peptides were hydrolyzed and, after dansylation, the hydrolysates were analyzed by HPLC.
Complete digestion of radiolabeled peptides with aminopeptidase M and carboxypeptidase Y and partial digestion with aminopeptidase M were
carried out as described in Materials and Methods. Blank values were used for background correction; the molar proportions of the components
of the peptides are given.
*Pen, degradation product of benzylpenicillin.
tUnder the standard conditions used the penicillin degradation product (Pen) and Glx (i.e., Glu) were eluted together. Where individual values
of Pen and Glx are given, the two components were quantitated separately by HPLC of the dansylated hydrolysates at pH 3.3 (13).
a linear 20-100% gradient of buffer F in buffer E over 144
min at a column temperature of 20°C and a flow rate of 0.7
ml/min. [Buffer E was 50 mM phosphate buffer, pH 4.0,
containing 0.15 mM sodium azide; buffer F was 70% (vol/
vol) methanol in 50 mM phosphate buffer, pH 4.0]. Radioac-
tively labeled peptides were lyophilized, hydrolyzed, and an-
alyzed as described above. The [14C]benzylpenicillin-labeled
tryptic peptides were completely digested with a mixture of
aminopeptidase M and carboxypeptidase Y and the reaction
products were separated by HPLC as described (13). The
pooled fractions from the radioactive peak were lyophilized,
hydrolyzed, and analyzed.
RESULTS
Isolation of the [14C]Benzylpenicillin-Labeled Tryptic Pep-
tides of PBPs 1A, 1B, and 3. Strains that carry the PBP 1A,
PBP 1B, and PBP 3 gene on runaway replication plasmids
were used to provide substantial amounts of these proteins
for purification. Purified PBPs 1A, 1B, and 3 (17, 33, and 99
nmol, respectively) were labeled with [14C]benzylpenicillin,
denatured, and digested with trypsin. The tryptic peptides
were separated by HPLC as described (13). Fractionation of
the peptides from both PBP 1A and PBP 1B resulted in only
one major radioactive peak; this material was further puri-
fied by HPLC under different elution conditions. With both
PBP 1A and PBP 1B, two major radioactive peptides were
resolved by the second HPLC separation (Fig. 1 A and B),
and their amino acid compositions were determined. Frac-
tionation of the tryptic digest of PBP 3 resulted in two radio-
active peptides (Fig. 1C) which were analyzed without fur-
ther purification. The radioactivity in the purified tryptic
peptides from PBPs 1A, 1B, and 3 accounted for 26-35% of
the radioactivity initially applied to the HPLC columns.
Amino Acid Compositions of [14C]Benzylpenicillin-Labeled
Tryptic Peptides of PBPs 1A, 1B, and 3. The two radioactive
peptides obtained from each of the PBPs were hydrolyzed
and their compositions were determined (Table 1). Frag-
ments I and II of PBP 1A (Fig. LA) were identical in amino
acid composition, as were fragments I and II ofPBP 1B (Fig.
1B). The differences in the retention times of the two frag-
ments obtained from PBP 1A and from PBP 1B were found
to be due to an unknown modification of the benzylpenicillin
moiety. In both cases, fragment I yielded a benzylpenicillin
degradation product that could not be dansylated, whereas
fragment II yielded a product that could be dansylated and
that was identical with that obtained by acid hydrolysis of
native benzylpenicillin. Fragment I from PBP 3 had the ami-
no acid composition shown in Table 1 and, in addition, con-
tained an unidentified compound. Fragment II from PBP 3
had the same amino acid composition as fragment I but con-
tained an extra valine as well as the unidentified compound.
The latter components may have arisen from fragmentation
of the benzylpenicillin and were only found in the analysis of
PBP 3.
Benzylpenicillin Is Bound to a Serine Residue of PBPs 1A,
1B, and 3. Complete digestion of the radiolabeled fragments
from PBP 1A, 1B, and 3 with a combination of aminopepti-
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FIG. 2. Purification of ['4C]benzylpenicillin-labeled fragments
produced by partial aminopeptidase M digestion of tryptic fragment
II of PBP 1B. The radiolabeled tryptic fragment 11 (450 pmol; see
Fig. 1B) was digested partially with aminopeptidase M, and the re-
sulting peptides were separated by HPLC. Fractions (210 Al) were
collected and those containing the three major radioactive peptides
were pooled (pool 1, fractions 288-290; pool 2, fractions 305-307;
pool 3, fractions 311-313), lyophilized, and hydrolyzed for amino
acid analysis.
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FIG. 3. Comparison of the penicillin-binding sites of PBP 1A, PBP 1B, PBP 3, and PBP 5 of E. coli. The amino acid sequences of PBPs 1A,
1B, and 3 were examined for regions with the amino acid composition obtained from the analysis of the benzylpenicillin-labeled peptides. The
peptide compositions corresponded to residues 462-470 of PBP 1A, residues 507-513 of PBP 1B, and residues 298-311 of PBP 3; the sequences
of these regions are shown. Arrowheads indicate the trypsin cleavage sites. The sequence around the active-site serine residue of the low M,
PBP 5 is shown for comparison (13, 23). The amino acid sequences of PBP 1A and PBP 1B are derived from the nucleotide sequences of the
ponA and ponB genes (unpublished data), and the sequences of PBP 3(22) and PBP 5(23) have been reported. The cleavage sites on the COOH-
terminal side of the penicilloylated serine residues are atypical. Contamination of trypsin with chymotrypsin would explain the cleavage site
observed with PBP 1A but not the cleavage between lysine and proline that occurs in PBP 1B. Proline at this position normally prevents trypsin
cleavage (24), and the presence of the penicilloylated serine may explain the unusual cleavage site. An influence of the amino acid composition
on the NH2-terminal side of potential trypsin cleavage sites has been described (24).
dase M and carboxypeptidase Y yielded radioactive prod-
ucts that were shown to contain penicillin and serine in equi-
molar proportions (Table 1). Benzylpenicillin therefore binds
to a serine residue in each of these high Mr PBPs. The radio-
labeled peptide from PBP 1B contained two serine residues,
either ofwhich could have been the residue acylated by peni-
cillin (Table 1). Amino acids were removed from the NH2
terminus of fragment II of PBP 1B by partial digestion with
aminopeptidase M and the products were separated by
HPLC (Fig. 2). Two of the three radiolabeled products were
obtained in sufficient quantities for amino acid analysis. The
major product (retention time, 73 min) contained serine, leu-
cine, alanine, lysine, and penicillin in equimolar amounts
(Table 1). The second product (retention time, 76.3 min) had
an identical composition except that it lacked lysine and pre-
sumably resulted from carboxypeptidase contamination of
the aminopeptidase preparation. The removal of one of the
serine residues of fragment II by aminopeptidase digestion
allowed the unambiguous identification of the serine residue
of PBP 1B that was acylated by penicillin (see below).
Sequence of the Benzylpenicillin-Labeled Peptides. The
amino acid sequences of PBP 1A and PBP 1B have been ob-
tained from the nucleotide sequences of the ponA and ponB
genes (unpublished data), and the sequence of PBP 3 has
been reported by Nakamura et al. (22). The sequences of
PBPs 1A, 1B, and 3 were scanned for regions that had the
amino acid composition of the corresponding penicillin-la-
beled tryptic peptide. The amino acid compositions of the
peptides (Table 1) corresponded exactly to sequences close
to the middle of PBPs 1A, 1B, and 3 (Fig. 3), and the residues
acylated by penicillin were identified as serine-465, serine-
510, and serine-307, respectively.
DISCUSSION
PBPs 1A, 1B, and 3 of E. coli catalyze both a penicillin-in-
sensitive peptidoglycan transglycosylase reaction and a pen-
icillin-sensitive peptidoglycan transpeptidase reaction (2).
We show here that inhibition of these PBPs occurs by peni-
cilloylation of a serine residue. By analogy with D-alanine
carboxypeptidases (10-13, 25), it is very likely that the same
serine residue is also acylated by cell-wall peptides during
transpeptidation and that the physiologically important high
Mr PBPs are serine peptidases. PBPs 1A and 1B show about
30%Z sequence identity, but neither protein shows any exten-
sive similarity to PBP 3 (unpublished data). The sequences
around the active-site serine residue of the three high Mr
PBPs, however, show clear similarities. In all three proteins,
the active-site serine residue occurs within the sequence
Gly-Ser-Xaa-Xaa-Lys-Pro, and at three nearby positions
identical amino acids are present in each high Mr PBP (Fig.
3).
The high Mr PBPs, D-alanine carboxypeptidases, and the
class A and class C f-lactamases show no extensive amino
acid sequence similarity (refs. 1, 17, 22, and 23 and unpub-
lished data) although all of these enzymes interact with peni-
cillin by a mechanism that involves acylation of a serine resi-
due. Even around the active-site serine residue, there is little
sequence similarity among the four classes of enzymes, ex-
cept that in all of these enzymes that recognize penicillin
[with the apparent exception of the D-alanine carboxypepti-
dase from Streptomyces strain R39 (26)], a lysine follows
three amino acids after the acylated serine residue (1, 11, 13,
17, and 23). The functional significance of the conserved ly-
sine is unknown, but presumably this residue has an impor-
tant role in catalysis or is involved in the binding of the car-
boxyl group of the peptide substrate and/or the f-lactam
molecules.
The location of the active-site serine residue close to the
middle of the high Mr PBPs contrasts with the position of the
acylated residue close to the NH2 terminus of the D-alanine
carboxypeptidases and ,B-lactamases (11, 13, 16, 17, and 23).
The latter classes of enzymes catalyze a single reaction,
whereas the high Mr PBPs are bifunctional, and the transgly-
cosylase activity of the high Mr PBPs may occupy an NH2-
terminal domain that is absent in the D-alanine carboxypepti-
dases and 8-lactamases (4). Support for this view has been
obtained by showing that the NH2-terminal 240 residues of
PBP 3 of E. coli can be removed without destroying the peni-
cillin-binding activity (27).
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